[1]
SMITA KHANDELWAL et al. 2016. ASSESSMENT OF ECONOMIC IMPACT AND DEVELOPMENT OF A PREDICTOR MODEL FOR TOTAL COST DUE TO ADVERSE DRUG REACTIONS IN CANCER PATIENTS ON CHEMOTHERAPY. International Journal of Pharma and Bio Sciences. 7, 2 (Jun. 2016), 234–242.